Menu
Recruiting NCT07044869

Effects of Facilitated Positional Release Technique ( FPRT) Vs Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome.

No phase Interventional Piriformis Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: FACILITATED POSITIONAL RELEASE TECHNIQUE, MANUAL MYOFASCIAL RELEASE TECHNIQUE.
Who it may be relevant to
Registry conditions: Piriformis Syndrome. Basic parameters: 25 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Facilitated Positional Release Technique( FPRT) Vs Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome.

Overview

This study is a randomized control trial, and the purpose of this study is to determine the "Effects of Facilitated Positional Release Technique ( FPRT) Vs Manual Myofascial Release Technique in Female Patients with Piriformis Syndrome.

Detailed description

The purpose of this study is to determine the "Effects of Facilitated positional release technique vs manual myofascial release technique in female patietns with piriformis syndrome.

we make 2 groups control and treatment group . we give FPRT technique to treatment group and manual release technique to control group in patients with piriformis syndrome.

first we take base line readings of HIP ROMS( abduction, adduction, internal rotation, external rotation),NPRS and LEFS(lower extremity functional scale)..

after 2 weeks of treatment again we take same readings and compare both readings.

Interventions

  • Procedure FACILITATED POSITIONAL RELEASE TECHNIQUE
    Participants in experimental group A receive FPRT as a main intervention along with piriformis stretches. 30 minutes' session starts with application of 10 minutes hot pack, followed by FPRT and stretches respectively. For FPRT, the patient position was prone with the hip flexion approximately (60°-90°) and abduction. The therapist was seated on the side that was affected, and the treated leg was hanging off the table with the knee bent resting on the therapist thigh. The painful tender area was
  • Procedure MANUAL MYOFASCIAL RELEASE TECHNIQUE
    Experimental Group B participants received MFRT as a main intervention along with application of hot pack and piriformis stretches. They also received 30 min session started with application of hot pack for 10 minutes followed by MFRT and piriformis stretches. For application of MFRT patient was in prone lying position. The therapist was standing at the affected/unaffected side of the patient. Myofascial release was provided, using the therapist's palm, finger pads or elbow directly on the pirif

Primary outcome measures

  • Piriformis Pain [Time frame: Before and after every 2 sessions for a total of 2 weeks]
  • Lower Extremity Functional Scale [Time frame: Before and after every 2 sessions for a total of 2 weeks]
  • Range of Motion [Time frame: Before and after every 2 sessions for a total of 2 weeks.]

Eligibility criteria

Inclusion criteria

  • • 25-50 years Only females Diagnosed piriformis syndrome Pain from 2 months

Exclusion criteria

  • Lumbar Radiculopathy Fracture trauma to lumbar spine surgery/ total hip replacement hip OA

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Foundation University College of Physical Therapy — Islamabad

Identifiers

NCT: NCT07044869 · FUI/CTR/2024/81

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗